Non‐clinical and first‐in‐human characterization of <scp>ECC5004</scp> / <scp>AZD5004</scp> , a novel once‐daily, oral small‐molecule <scp>GLP</scp> ‐1 receptor agonist
Authors
- Aruni Jha (ORCID: https://orcid.org/0000-0002-7339-2725)
- Alessandro Boianelli (ORCID: https://orcid.org/0000-0003-2193-9415)
- Natalie R. van Zuydam (ORCID: https://orcid.org/0000-0002-9809-1398)
- Karin Nelander (ORCID: https://orcid.org/0000-0002-2649-1130)
- Graeme Davies
- Jianfeng Xu (ORCID: https://orcid.org/0000-0002-1343-8752)
- Sandra Pagnussat
- Bertil Lindmark
- Laurie Butcher
- Amina Z. Haggag
- Sara Lundqvist (ORCID: https://orcid.org/0000-0001-9717-8347)
- Kristina Wallenius (ORCID: https://orcid.org/0000-0002-3231-2733)
- Hongtao Yu (ORCID: https://orcid.org/0000-0003-2278-4478)
- Xiaoliang Pan (ORCID: https://orcid.org/0000-0002-6399-4853)
- Haihui Liu (ORCID: https://orcid.org/0000-0002-7401-6967)
- Wengang Chen (ORCID: https://orcid.org/0000-0002-0778-1861)
- Xuefeng Sun
- Anna Ollerstam
- Jingye Zhou (ORCID: https://orcid.org/0000-0002-8767-3878)
- Wenyu Wang (ORCID: https://orcid.org/0009-0005-3970-7040)
- Fan Wang (ORCID: https://orcid.org/0000-0002-2245-3671)
Institutions
- AstraZeneca (United Kingdom) (GB)
- Anaheim Clinical Trials (US)
- Addgene (US)
- Miami-Dade County Public Schools (US)
- AstraZeneca (Sweden) (SE)
- AstraZeneca (United States) (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1111/dom.16047
- Citations
- 12
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.29